UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 253

Sortiert nach

Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck

The New England journal of medicine, 2016-11, Vol.375 (19), p.1856-1867

2016

Link zum Volltext

Verfügbarkeit prüfen

Comparison of 2D- and 3D-culture models as drug-testing platforms in breast cancer

Oncology reports, 2015-04, Vol.33 (4), p.1837-1843

2015

Link zum Volltext

Verfügbarkeit prüfen

Subgroup analysis of Japanese patients in a phase 3 study of lenvatinib in radioiodine‐refractory differentiated thyroid cancer

Cancer science, 2015-12, Vol.106 (12), p.1714-1721

2015

Link zum Volltext

Verfügbarkeit prüfen

Weekly Low‐Dose Versus Three‐Weekly High‐Dose Cisplatin for Concurrent Chemoradiation in Locoregionally Advanced Non‐Nasopharyngeal Head and Neck Cancer: A Systematic Review and Meta‐Analysis of Aggregate Data

The oncologist (Dayton, Ohio), 2017-09, Vol.22 (9), p.1056-1066

2017

Link zum Volltext

Verfügbarkeit prüfen

Immunotherapy for squamous cell carcinoma of the head and neck

Japanese journal of clinical oncology, 2020-10, Vol.50 (10), p.1089-1096

2020

Link zum Volltext

Verfügbarkeit prüfen

Controversies in relation to neck management in N0 early oral tongue cancer

Japanese journal of clinical oncology, 2019-04, Vol.49 (4), p.297-305

2019

Link zum Volltext

Verfügbarkeit prüfen

Treatment‐emergent hypertension and efficacy in the phase 3 Study of (E7080) lenvatinib in differentiated cancer of the thyroid (SELECT)

Cancer, 2018-06, Vol.124 (11), p.2365-2372

2018

Link zum Volltext

Verfügbarkeit prüfen

Low-Dose vs. High-Dose Cisplatin: Lessons Learned From 59 Chemoradiotherapy Trials in Head and Neck Cancer

Frontiers in oncology, 2019-02, Vol.9, p.86-86

2019

Link zum Volltext

Verfügbarkeit prüfen

Risk factors for osteoradionecrosis of the jaw in patients with head and neck squamous cell carcinoma

Radiation oncology (London, England), 2021-01, Vol.16 (1), p.1-11, Article 1

2021

Link zum Volltext

Verfügbarkeit prüfen

Phase II study of the efficacy and safety of lenvatinib for anaplastic thyroid cancer (HOPE)

European journal of cancer (1990), 2022-09, Vol.173, p.210-218

2022

Link zum Volltext

Verfügbarkeit prüfen

SY33-1 Novel treatment strategy for advanced differentiated thyroid cancer

Annals of oncology, 2021-07, Vol.32, p.S274-S274

Kiyota, Naomi

2021

Link zum Volltext

Verfügbarkeit prüfen

Induction chemotherapy in locally advanced squamous cell carcinoma of the head and neck

Japanese journal of clinical oncology, 2021-02, Vol.51 (2), p.173-179

2021

Link zum Volltext

Verfügbarkeit prüfen

Device-related Mycobacterium mageritense Infection in a Patient Treated with Nivolumab for Metastatic Breast Cancer

Internal Medicine, 2021/11/01, Vol.60(21), pp.3485-3488

2021

Link zum Volltext

Verfügbarkeit prüfen

Real-world safety and effectiveness of nivolumab for recurrent or metastatic head and neck cancer in Japan: a post-marketing surveillance

International journal of clinical oncology, 2021-09, Vol.26 (9), p.1619-1627

2021

Link zum Volltext

Verfügbarkeit prüfen

Limited increase in antibody titers following mRNA SARS-CoV-2 vaccination for more than 3 years after final dose of anti-CD20 antibody

International journal of hematology, 2022, Vol.115 (1), p.7-10

2022

Link zum Volltext

Verfügbarkeit prüfen

Exploratory analysis of prognostic factors for lenvatinib in radioiodine‐refractory differentiated thyroid cancer

Head & neck, 2019-09, Vol.41 (9), p.3023-3032

2019

Link zum Volltext

Verfügbarkeit prüfen

A review of head and neck cancer staging system in the TNM classification of malignant tumors (eighth edition)

Japanese journal of clinical oncology, 2019-07, Vol.49 (7), p.589-595

2019

Link zum Volltext

Verfügbarkeit prüfen

Human papillomavirus-related oropharyngeal carcinoma

Japanese journal of clinical oncology, 2022-07, Vol.52 (7), p.700-706

2022

Link zum Volltext

Verfügbarkeit prüfen

Clinical impact of cachexia in unresectable locally advanced head and neck cancer: supplementary analysis of a phase II trial (JCOG0706-S2)

Japanese journal of clinical oncology, 2019-01, Vol.49 (1), p.37-41

2019

Link zum Volltext

Verfügbarkeit prüfen

Management of elderly patients with head and neck cancer

Japanese journal of clinical oncology, 2022-04, Vol.52 (4), p.313-321

2022

Link zum Volltext

Verfügbarkeit prüfen

Randomized phase III study to evaluate the value of omission of prophylactic neck dissection for stage I/II tongue cancer: Japan Clinical Oncology Group study (JCOG1601, RESPOND)

Japanese journal of clinical oncology, 2018-12, Vol.48 (12), p.1105-1108

2018

Link zum Volltext

Verfügbarkeit prüfen

Serum Soluble Interleukin-2 Receptor as a Potential Biomarker for Immune-related Adverse Events

Anticancer research, 2021-02, Vol.41 (2), p.1021-1026

2021

Link zum Volltext

Verfügbarkeit prüfen

Guidelines for clinical evaluation of anti‐cancer drugs

Cancer science, 2021-07, Vol.112 (7), p.2563-2577

2021

Link zum Volltext

Verfügbarkeit prüfen

Novel approach of prophylactic radiation to reduce toxicities comparing 2-step40 with 56-Gy simultaneous integrated boost intensity-modulated radiation therapy for locally advanced squamous cell carcinoma of the head and neck, an intergroup phase III trial (JCOG1912, NEW BRIDGE)

BMC cancer, 2023-11, Vol.23 (1), p.1-1068, Article 1068

2023

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 253

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(240)
Mit Volltextzugriff
(245)

Publikationsform

Artikel
(249)
Berichte
(4)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck

Comparison of 2D- and 3D-culture models as drug-testing platforms in breast cancer

Subgroup analysis of Japanese patients in a phase 3 study of lenvatinib in radioiodine‐refractory differentiated thyroid cancer

Weekly Low‐Dose Versus Three‐Weekly High‐Dose Cisplatin for Concurrent Chemoradiation in Locoregionally Advanced Non‐Nasopharyngeal Head and Neck Cancer: A Systematic Review and Meta‐Analysis of Aggregate Data

Immunotherapy for squamous cell carcinoma of the head and neck

Nivolumab Plus Ipilimumab Versus EXTREME Regimen as First-Line Treatment for Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck: The Final Results of CheckMate 651

Controversies in relation to neck management in N0 early oral tongue cancer

Treatment‐emergent hypertension and efficacy in the phase 3 Study of (E7080) lenvatinib in differentiated cancer of the thyroid (SELECT)

Low-Dose vs. High-Dose Cisplatin: Lessons Learned From 59 Chemoradiotherapy Trials in Head and Neck Cancer

Risk factors for osteoradionecrosis of the jaw in patients with head and neck squamous cell carcinoma

Phase II study of the efficacy and safety of lenvatinib for anaplastic thyroid cancer (HOPE)

SY33-1 Novel treatment strategy for advanced differentiated thyroid cancer

Induction chemotherapy in locally advanced squamous cell carcinoma of the head and neck

Device-related Mycobacterium mageritense Infection in a Patient Treated with Nivolumab for Metastatic Breast Cancer

Real-world safety and effectiveness of nivolumab for recurrent or metastatic head and neck cancer in Japan: a post-marketing surveillance

Limited increase in antibody titers following mRNA SARS-CoV-2 vaccination for more than 3 years after final dose of anti-CD20 antibody

Exploratory analysis of prognostic factors for lenvatinib in radioiodine‐refractory differentiated thyroid cancer

A review of head and neck cancer staging system in the TNM classification of malignant tumors (eighth edition)

Human papillomavirus-related oropharyngeal carcinoma

Clinical impact of cachexia in unresectable locally advanced head and neck cancer: supplementary analysis of a phase II trial (JCOG0706-S2)

Management of elderly patients with head and neck cancer

Randomized phase III study to evaluate the value of omission of prophylactic neck dissection for stage I/II tongue cancer: Japan Clinical Oncology Group study (JCOG1601, RESPOND)

Serum Soluble Interleukin-2 Receptor as a Potential Biomarker for Immune-related Adverse Events

Guidelines for clinical evaluation of anti‐cancer drugs

Novel approach of prophylactic radiation to reduce toxicities comparing 2-step40 with 56-Gy simultaneous integrated boost intensity-modulated radiation therapy for locally advanced squamous cell carcinoma of the head and neck, an intergroup phase III trial (JCOG1912, NEW BRIDGE)

Suchergebnisse filtern